Logo image of BAKKA.OL

BAKKAFROST P/F (BAKKA.OL) Stock Fundamental Analysis

OSL:BAKKA - Euronext Oslo - FO0000000179 - Common Stock - Currency: NOK

511  +10 (+2%)

Fundamental Rating

6

Overall BAKKA gets a fundamental rating of 6 out of 10. We evaluated BAKKA against 58 industry peers in the Food Products industry. BAKKA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BAKKA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year BAKKA was profitable.
BAKKA had a positive operating cash flow in the past year.
In the past 5 years BAKKA has always been profitable.
BAKKA had a positive operating cash flow in each of the past 5 years.
BAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFBAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B -3B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.72%, BAKKA is in line with its industry, outperforming 50.00% of the companies in the same industry.
The Return On Equity of BAKKA (5.88%) is comparable to the rest of the industry.
BAKKA has a Return On Invested Capital (6.24%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for BAKKA is in line with the industry average of 7.19%.
Industry RankSector Rank
ROA 3.72%
ROE 5.88%
ROIC 6.24%
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
BAKKA.OL Yearly ROA, ROE, ROICBAKKA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of BAKKA (8.95%) is better than 75.86% of its industry peers.
BAKKA's Profit Margin has declined in the last couple of years.
BAKKA has a Operating Margin of 18.10%. This is amongst the best in the industry. BAKKA outperforms 86.21% of its industry peers.
BAKKA's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 69.93%, BAKKA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of BAKKA has remained more or less at the same level.
Industry RankSector Rank
OM 18.1%
PM (TTM) 8.95%
GM 69.93%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
BAKKA.OL Yearly Profit, Operating, Gross MarginsBAKKA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BAKKA is destroying value.
BAKKA has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for BAKKA has been increased compared to 5 years ago.
Compared to 1 year ago, BAKKA has an improved debt to assets ratio.
BAKKA.OL Yearly Shares OutstandingBAKKA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BAKKA.OL Yearly Total Debt VS Total AssetsBAKKA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 3.16 indicates that BAKKA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.16, BAKKA is in the better half of the industry, outperforming 79.31% of the companies in the same industry.
The Debt to FCF ratio of BAKKA is 2.84, which is a good value as it means it would take BAKKA, 2.84 years of fcf income to pay off all of its debts.
BAKKA has a Debt to FCF ratio of 2.84. This is amongst the best in the industry. BAKKA outperforms 84.48% of its industry peers.
BAKKA has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BAKKA (0.33) is better than 77.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.84
Altman-Z 3.16
ROIC/WACC0.78
WACC8.05%
BAKKA.OL Yearly LT Debt VS Equity VS FCFBAKKA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

BAKKA has a Current Ratio of 6.75. This indicates that BAKKA is financially healthy and has no problem in meeting its short term obligations.
BAKKA has a better Current ratio (6.75) than 98.28% of its industry peers.
A Quick Ratio of 1.78 indicates that BAKKA should not have too much problems paying its short term obligations.
BAKKA has a Quick ratio of 1.78. This is amongst the best in the industry. BAKKA outperforms 86.21% of its industry peers.
Industry RankSector Rank
Current Ratio 6.75
Quick Ratio 1.78
BAKKA.OL Yearly Current Assets VS Current LiabilitesBAKKA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

6

3. Growth

3.1 Past

BAKKA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.61%.
The Earnings Per Share has been decreasing by -1.36% on average over the past years.
BAKKA shows a small growth in Revenue. In the last year, the Revenue has grown by 2.70%.
BAKKA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.21% yearly.
EPS 1Y (TTM)5.61%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%22.75%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-5.9%

3.2 Future

BAKKA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.37% yearly.
BAKKA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.35% yearly.
EPS Next Y19.21%
EPS Next 2Y26.38%
EPS Next 3Y26.37%
EPS Next 5YN/A
Revenue Next Year3.47%
Revenue Next 2Y11.72%
Revenue Next 3Y11.35%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BAKKA.OL Yearly Revenue VS EstimatesBAKKA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
BAKKA.OL Yearly EPS VS EstimatesBAKKA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.46 indicates a rather expensive valuation of BAKKA.
BAKKA's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.78, BAKKA is valued a bit cheaper.
A Price/Forward Earnings ratio of 14.65 indicates a correct valuation of BAKKA.
BAKKA's Price/Forward Earnings ratio is in line with the industry average.
BAKKA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.32.
Industry RankSector Rank
PE 17.46
Fwd PE 14.65
BAKKA.OL Price Earnings VS Forward Price EarningsBAKKA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

BAKKA's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, BAKKA is valued a bit cheaper than the industry average as 63.79% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.38
EV/EBITDA 10.84
BAKKA.OL Per share dataBAKKA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

BAKKA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of BAKKA may justify a higher PE ratio.
BAKKA's earnings are expected to grow with 26.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.91
PEG (5Y)N/A
EPS Next 2Y26.38%
EPS Next 3Y26.37%

4

5. Dividend

5.1 Amount

BAKKA has a Yearly Dividend Yield of 2.60%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.09, BAKKA has a dividend in line with its industry peers.
BAKKA's Dividend Yield is comparable with the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 2.6%

5.2 History

The dividend of BAKKA has a limited annual growth rate of 3.15%.
Dividend Growth(5Y)3.15%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

BAKKA pays out 78.48% of its income as dividend. This is not a sustainable payout ratio.
BAKKA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP78.48%
EPS Next 2Y26.38%
EPS Next 3Y26.37%
BAKKA.OL Yearly Income VS Free CF VS DividendBAKKA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B
BAKKA.OL Dividend Payout.BAKKA.OL Dividend Payout, showing the Payout Ratio.BAKKA.OL Dividend Payout.PayoutRetained Earnings

BAKKAFROST P/F

OSL:BAKKA (4/28/2025, 3:18:38 PM)

511

+10 (+2%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-17 2025-02-17/bmo
Earnings (Next)05-19 2025-05-19
Inst Owners63%
Inst Owner ChangeN/A
Ins Owners16.05%
Ins Owner ChangeN/A
Market Cap30.30B
Analysts76.67
Price Target661.53 (29.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.6%
Yearly Dividend13.79
Dividend Growth(5Y)3.15%
DP78.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.95%
Min EPS beat(2)-51.09%
Max EPS beat(2)-2.8%
EPS beat(4)1
Avg EPS beat(4)-18.91%
Min EPS beat(4)-51.09%
Max EPS beat(4)1.9%
EPS beat(8)3
Avg EPS beat(8)-12.34%
EPS beat(12)3
Avg EPS beat(12)-14.45%
EPS beat(16)4
Avg EPS beat(16)-16.18%
Revenue beat(2)0
Avg Revenue beat(2)-15.63%
Min Revenue beat(2)-18.93%
Max Revenue beat(2)-12.34%
Revenue beat(4)1
Avg Revenue beat(4)-9.34%
Min Revenue beat(4)-18.93%
Max Revenue beat(4)2.47%
Revenue beat(8)2
Avg Revenue beat(8)-4.31%
Revenue beat(12)5
Avg Revenue beat(12)-2.7%
Revenue beat(16)6
Avg Revenue beat(16)-2.83%
PT rev (1m)-5.43%
PT rev (3m)-13.5%
EPS NQ rev (1m)-24.49%
EPS NQ rev (3m)-41.18%
EPS NY rev (1m)-3.06%
EPS NY rev (3m)-14.73%
Revenue NQ rev (1m)-2.68%
Revenue NQ rev (3m)-21.79%
Revenue NY rev (1m)-3.43%
Revenue NY rev (3m)-10.9%
Valuation
Industry RankSector Rank
PE 17.46
Fwd PE 14.65
P/S 2.61
P/FCF 14.38
P/OCF 8.11
P/B 1.71
P/tB 2.87
EV/EBITDA 10.84
EPS(TTM)29.26
EY5.73%
EPS(NY)34.89
Fwd EY6.83%
FCF(TTM)35.54
FCFY6.96%
OCF(TTM)62.99
OCFY12.33%
SpS196.16
BVpS298.65
TBVpS177.81
PEG (NY)0.91
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.72%
ROE 5.88%
ROCE 7.85%
ROIC 6.24%
ROICexc 6.42%
ROICexgc 8.86%
OM 18.1%
PM (TTM) 8.95%
GM 69.93%
FCFM 18.12%
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
ROICexc(3y)6.94%
ROICexc(5y)5.73%
ROICexgc(3y)9.65%
ROICexgc(5y)8.22%
ROCE(3y)8.44%
ROCE(5y)6.96%
ROICexcg growth 3Y13.09%
ROICexcg growth 5Y-10.07%
ROICexc growth 3Y16.55%
ROICexc growth 5Y-6.46%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
F-Score6
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.84
Debt/EBITDA 1.83
Cap/Depr 145.7%
Cap/Sales 13.99%
Interest Coverage 250
Cash Conversion 115.89%
Profit Quality 202.37%
Current Ratio 6.75
Quick Ratio 1.78
Altman-Z 3.16
F-Score6
WACC8.05%
ROIC/WACC0.78
Cap/Depr(3y)180.8%
Cap/Depr(5y)188.01%
Cap/Sales(3y)15.4%
Cap/Sales(5y)16.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.61%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%22.75%
EPS Next Y19.21%
EPS Next 2Y26.38%
EPS Next 3Y26.37%
EPS Next 5YN/A
Revenue 1Y (TTM)2.7%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-5.9%
Revenue Next Year3.47%
Revenue Next 2Y11.72%
Revenue Next 3Y11.35%
Revenue Next 5YN/A
EBIT growth 1Y-4.55%
EBIT growth 3Y25.01%
EBIT growth 5Y1.6%
EBIT Next Year76.1%
EBIT Next 3Y34.81%
EBIT Next 5YN/A
FCF growth 1Y3475.19%
FCF growth 3Y431.02%
FCF growth 5YN/A
OCF growth 1Y130.26%
OCF growth 3Y27.94%
OCF growth 5Y17.84%